These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 22033914)
1. [Prevention in chronic obstructive pulmonary disease. POET-COPD (prevention of exacerbations with tiotropium in COPD)]. Gillissen A; Nitschmann S Internist (Berl); 2011 Dec; 52(12):1492-4. PubMed ID: 22033914 [No Abstract] [Full Text] [Related]
2. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM; N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765 [TBL] [Abstract][Full Text] [Related]
3. Tiotropium versus salmeterol in COPD. Schembri S N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714655 [No Abstract] [Full Text] [Related]
4. Tiotropium versus salmeterol in COPD. Lloret-Linares C; Bergmann JF N Engl J Med; 2011 Jun; 364(26):2552-3; author reply 2553-4. PubMed ID: 21714656 [No Abstract] [Full Text] [Related]
5. Tiotropium versus salmeterol in COPD. Oba Y N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714654 [No Abstract] [Full Text] [Related]
6. Choice of bronchodilator therapy for patients with COPD. Wedzicha JA N Engl J Med; 2011 Mar; 364(12):1167-8. PubMed ID: 21428773 [No Abstract] [Full Text] [Related]
7. A study to assess COPD Symptom-based Management and to Optimise treatment Strategy in Japan (COSMOS-J) based on GOLD 2011. Betsuyaku T; Kato M; Fujimoto K; Hagan G; Kobayashi A; Hitosugi H; James M; Jones PW Int J Chron Obstruct Pulmon Dis; 2013; 8():453-9. PubMed ID: 24124358 [TBL] [Abstract][Full Text] [Related]
8. Tiotropium step-up therapy in asthma. Miller DR; Chetty M; Currie GP N Engl J Med; 2011 Feb; 364(6):578; author reply 578-9. PubMed ID: 21306256 [No Abstract] [Full Text] [Related]
9. A US database study characterizing patients initiating a budesonide-formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease. Kern DM; Williams SA; Tunceli O; Wessman C; Zhou S; Pethick N; Elhefni H; Trudo F Int J Chron Obstruct Pulmon Dis; 2014; 9():775-83. PubMed ID: 25071369 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients. Beier J; van Noord J; Deans A; Brooks J; Maden C; Baggen S; Mehta R; Cahn A Int J Chron Obstruct Pulmon Dis; 2012; 7():153-64. PubMed ID: 22419863 [TBL] [Abstract][Full Text] [Related]
11. Summaries for patients. Combination inhaler therapy for chronic obstructive pulmonary disease. Ann Intern Med; 2007 Apr; 146(8):I12. PubMed ID: 17310044 [No Abstract] [Full Text] [Related]
12. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Aaron SD; Vandemheen KL; Fergusson D; Maltais F; Bourbeau J; Goldstein R; Balter M; O'Donnell D; McIvor A; Sharma S; Bishop G; Anthony J; Cowie R; Field S; Hirsch A; Hernandez P; Rivington R; Road J; Hoffstein V; Hodder R; Marciniuk D; McCormack D; Fox G; Cox G; Prins HB; Ford G; Bleskie D; Doucette S; Mayers I; Chapman K; Zamel N; FitzGerald M; Ann Intern Med; 2007 Apr; 146(8):545-55. PubMed ID: 17310045 [TBL] [Abstract][Full Text] [Related]
13. Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease. Dalal AA; Roberts MH; Petersen HV; Blanchette CM; Mapel DW Int J Chron Obstruct Pulmon Dis; 2010 Dec; 6():13-22. PubMed ID: 21311689 [TBL] [Abstract][Full Text] [Related]
14. Anticholinergics for patients with asthma? Smith LJ N Engl J Med; 2010 Oct; 363(18):1764-5. PubMed ID: 20979479 [No Abstract] [Full Text] [Related]
15. Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations. Beeh KM; Hederer B; Glaab T; Müller A; Rutten-van Moelken M; Kesten S; Vogelmeier C Int J Chron Obstruct Pulmon Dis; 2009; 4():119-25. PubMed ID: 19436693 [TBL] [Abstract][Full Text] [Related]
16. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. Peters SP; Kunselman SJ; Icitovic N; Moore WC; Pascual R; Ameredes BT; Boushey HA; Calhoun WJ; Castro M; Cherniack RM; Craig T; Denlinger L; Engle LL; DiMango EA; Fahy JV; Israel E; Jarjour N; Kazani SD; Kraft M; Lazarus SC; Lemanske RF; Lugogo N; Martin RJ; Meyers DA; Ramsdell J; Sorkness CA; Sutherland ER; Szefler SJ; Wasserman SI; Walter MJ; Wechsler ME; Chinchilli VM; Bleecker ER; N Engl J Med; 2010 Oct; 363(18):1715-26. PubMed ID: 20979471 [TBL] [Abstract][Full Text] [Related]
17. Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patients. Vogelmeier C; Fabbri LM; Rabe KF; Beeh KM; Schmidt H; Metzdorf N; Glaab T Respir Med; 2013 Jan; 107(1):75-83. PubMed ID: 23102611 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of GSK961081, a bi-functional molecule, in patients with COPD. Bateman ED; Kornmann O; Ambery C; Norris V Pulm Pharmacol Ther; 2013 Oct; 26(5):581-7. PubMed ID: 23538170 [TBL] [Abstract][Full Text] [Related]
19. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Cramer JA; Bradley-Kennedy C; Scalera A Can Respir J; 2007; 14(1):25-9. PubMed ID: 17315055 [TBL] [Abstract][Full Text] [Related]
20. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial. Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]